pJ3H-Mst1 Citations (5)

Originally described in: The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain.
Creasy CL, Ambrose DM, Chernoff J J Biol Chem. 1996 Aug 30. 271(35):21049-53. PubMed Journal

---

Articles Citing pJ3H-Mst1

Articles
Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling. Archibald A, Al-Masri M, Liew-Spilger A, McCaffrey L. Mol Biol Cell. 2015 Oct 15;26(20):3578-95. doi: 10.1091/mbc.E15-05-0265. Epub 2015 Aug 12. PubMed
MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Cui J, Zhou Z, Yang H, Jiao F, Li N, Gao Y, Wang L, Chen J, Quan M. Mol Cancer Res. 2019 Jun;17(6):1316-1325. doi: 10.1158/1541-7786.MCR-18-0910. Epub 2019 Feb 22. PubMed
MST1 inhibits cell proliferation and invasion of non-small-cell lung cancer by regulating YAP phosphorylation and Hippo pathway. Liu XF, Han Q, Yang M, Lin XY, Han YC. Int J Clin Exp Pathol. 2018 May 1;11(5):2613-2620. eCollection 2018. PubMed
The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling. Stoner SA, Liu KTH, Andrews ET, Liu M, Arimoto KI, Yan M, Davis AG, Weng S, Dow M, Xian S, DeKelver RC, Carter H, Zhang DE. Blood Cancer J. 2020 Feb 6;10(2):16. doi: 10.1038/s41408-020-0282-9. PubMed
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Shu B, Zhou Y, Lei G, Peng Y, Ding C, Li Z, He C. Cancer Sci. 2024 May;115(5):1476-1491. doi: 10.1111/cas.16134. Epub 2024 Mar 12. PubMed

If you have published an article using this material, please email us at to have your article added to this page.